No Picture
Los Angeles Biotech Trending News

Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 3Q21 and YTD 3Q21 Net Income per Share – Diluted of $0.67 and $3.38, respectively; 3Q21 and YTD 3Q21 FFO per Share – Diluted, As Adjusted, of $1.95 and $5.80, respectively

PASADENA, Calif.: PASADENA, Calif., Oct. 25, 2021 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the third quarter ended September 30, 2021. Key highlights YTD Operating results 3Q21 3Q20 […]

No Picture
Los Angeles Biotech Trending News

STAT+: Pharmalittle: Most pharma money went to Dems holding up drug-pricing reform; European officials raid pharma animal health company

Democratic lawmakers holding up proposed drug-pricing reform are among the largest beneficiaries of a pharmaceutical industry push to stave off price cuts. Click to view original post

No Picture
Los Angeles Biotech Trending News

NKGen Biotech Announces Acceptance of SNK01 Abstract for Presentation at the 2021 Connective Tissue Oncology Society Annual Meeting

SANTA ANA, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) — NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, today announced that a […]

No Picture
Los Angeles Biotech Trending News

AstraZeneca’s MCL-1 cancer drug put on hold after flagging a safety issue — 2 years after Amgen axed rival drug

Two years after the FDA hit Amgen with a clinical hold on its MCL-1 inhibitor AMG 397 following signs of cardiac toxicity, AstraZeneca is now flagging safety issues for a rival therapy of the same […]

No Picture
Los Angeles Biotech Trending News

Aadi Bioscience to Participate in H.C. Wainwright’s 2nd Annual Precision Oncology Conference 2021

LOS ANGELES, Oct. 19, 2021 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (“Aadi”), a privately-held clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief […]

No Picture
Los Angeles Biotech Trending News

Potential Cure For HIV Successfully Completes Pre-investigational New Drug (Pre-Ind) Stage Of FDA Approval Process

LOS ANGELES: LOS ANGELES, Oct. 19, 2021 /PRNewswire/ — (NASDAQ: ENOB) − A potential cure for HIV, developed by pioneering research scientist Dr. Serhat Gumrukçu, Director of the Seraph Research Institute (SRI), and his team […]

No Picture
Los Angeles Biotech Trending News

Amgen Successfully Completes Acquisition Of Teneobio, Inc.

THOUSAND OAKS, Calif.: THOUSAND OAKS, Calif., Oct. 19, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio). Effective as of Oct. 19, 2021, […]

No Picture
Los Angeles Biotech Trending News

NEW BRIEF: Focus Groups Overwhelming Disapprove of Government "Negotiated" Drug Pricing

PASADENA, Calif.: PASADENA, Calif., Oct. 19, 2021 /PRNewswire/ — Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion […]